ELDON BIOLOGICALS A/S — Credit Rating and Financial Key Figures

CVR number: 26747007
Sandtoften 10, 2820 Gentofte

Income statement (kDKK)

20192020202120222023
Fiscal period length1212121212
Net sales
Gross profit14 331.4019 531.4416 382.6512 307.3914 865.49
Employee benefit expenses-6 258.14-8 031.96-6 163.43-5 555.69-7 407.28
Other operating expenses-15.91
Total depreciation- 406.79- 404.11- 391.22- 405.24- 352.66
EBIT7 666.4711 095.379 828.006 346.467 089.64
Other financial income1 066.661 012.16594.311 096.491 673.20
Other financial expenses- 256.74- 538.11-4 376.83- 447.56- 260.28
Net income from associates (fin.)142.14- 142.14
Pre-tax profit8 476.3911 569.426 187.626 853.248 502.56
Income taxes-1 867.70-2 471.00-1 215.80-1 490.58-1 828.92
Net earnings6 608.699 098.424 971.825 362.666 673.64

Assets (kDKK)

20192020202120222023
Development expenditure2 786.625 284.96
Intangible assets total2 786.625 284.96
Machinery and equipment1 385.001 173.17781.94462.20170.63
Tangible assets total1 385.001 173.17781.94462.20170.63
Holdings in group member companies142.14
Other receivables160.80179.10195.87222.15229.83
Investments total160.80179.10338.01222.15229.83
Long term receivables total
Finished products/goods1 974.132 129.562 132.492 850.013 080.65
Advance payments17.50
Inventories total1 974.132 129.562 149.992 850.013 080.65
Current trade debtors3 628.931 947.162 672.072 243.042 147.61
Current amounts owed by group member comp.12.521 377.473 375.478 633.81
Prepayments and accrued income102.45135.73113.17222.64167.00
Current other receivables244.8342.90350.46384.80537.92
Short term receivables total3 976.222 138.304 513.166 225.9511 486.34
Other current investments2 151.397 137.792 948.183 956.874 616.44
Cash and bank deposits12 324.0319 588.7624 750.2823 083.8321 844.32
Cash and cash equivalents14 475.4226 726.5427 698.4727 040.7026 460.76
Balance sheet total (assets)21 971.5732 346.6735 481.5839 587.6346 713.17

Equity and liabilities (kDKK)

20192020202120222023
Share capital500.00500.00500.00500.00500.00
Shares repurchased500.00500.00500.001 000.002 000.00
Other reserves2 786.624 735.32
Retained earnings8 940.3715 049.0523 647.4724 832.6726 246.63
Profit of the financial year6 608.699 098.424 971.825 362.666 673.64
Shareholders equity total16 549.0625 147.4729 619.2934 481.9540 155.60
Provisions153.22148.25139.97162.01693.32
Non-current accruals and deferred income340.40
Non-current liabilities total340.40
Current loans from credit institutions34.43
Advances received103.89
Current trade creditors526.881 159.931 538.561 252.621 215.63
Current owed to participating1 681.401 291.99913.90521.93113.98
Current owed to group member996.182 021.144.44633.98
Short-term deferred tax liabilities1 221.441 466.461 293.35
Other non-interest bearing current liabilities2 064.832 577.891 944.531 663.792 266.92
Current liabilities total5 269.307 050.955 722.314 943.665 523.86
Balance sheet total (liabilities)21 971.5732 346.6735 481.5839 587.6346 713.17
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.